1. Home
  2. ANIP vs HDL Comparison

ANIP vs HDL Comparison

Compare ANIP & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • HDL
  • Stock Information
  • Founded
  • ANIP 2001
  • HDL 2016
  • Country
  • ANIP United States
  • HDL Singapore
  • Employees
  • ANIP N/A
  • HDL N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • HDL Restaurants
  • Sector
  • ANIP Health Care
  • HDL Consumer Discretionary
  • Exchange
  • ANIP Nasdaq
  • HDL Nasdaq
  • Market Cap
  • ANIP 1.2B
  • HDL 1.4B
  • IPO Year
  • ANIP N/A
  • HDL 2024
  • Fundamental
  • Price
  • ANIP $57.94
  • HDL $22.70
  • Analyst Decision
  • ANIP Buy
  • HDL
  • Analyst Count
  • ANIP 7
  • HDL 0
  • Target Price
  • ANIP $77.33
  • HDL N/A
  • AVG Volume (30 Days)
  • ANIP 172.8K
  • HDL 10.6K
  • Earning Date
  • ANIP 02-28-2025
  • HDL 03-04-2025
  • Dividend Yield
  • ANIP N/A
  • HDL N/A
  • EPS Growth
  • ANIP N/A
  • HDL N/A
  • EPS
  • ANIP N/A
  • HDL 0.09
  • Revenue
  • ANIP $555,456,000.00
  • HDL $759,894,000.00
  • Revenue This Year
  • ANIP $25.54
  • HDL $18.96
  • Revenue Next Year
  • ANIP $20.95
  • HDL $14.25
  • P/E Ratio
  • ANIP N/A
  • HDL $25.74
  • Revenue Growth
  • ANIP 23.60
  • HDL 16.09
  • 52 Week Low
  • ANIP $52.50
  • HDL $13.94
  • 52 Week High
  • ANIP $70.81
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 46.25
  • HDL N/A
  • Support Level
  • ANIP $58.37
  • HDL N/A
  • Resistance Level
  • ANIP $60.54
  • HDL N/A
  • Average True Range (ATR)
  • ANIP 1.69
  • HDL 0.00
  • MACD
  • ANIP -0.21
  • HDL 0.00
  • Stochastic Oscillator
  • ANIP 20.28
  • HDL 0.00

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.

Share on Social Networks: